BioAdaptives
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-653.90-2.18K-5.14K-10.45K-593.91-1.76K-136.22-76.55-17.66-117.70-0.04-593.91
Price/Sales ratio
N/AN/A46.32KN/AN/A78.04K8.99K5.11K1.11K2.93K2.7478.04K
Price/Book Value ratio
-14.39M-2.44K-5.00K186.48K-1.20K-923.10-106.46-92.61-13.14-50.92-0.05-1.20K
Price/Cash Flow ratio
-28.72K-6.89M158.29K-1.21M-2.07K-4.61K-1.37K-638.05-83.96-374.75-0.20-2.07K
Price/Free Cash Flow ratio
-27.97K-6.89M158.29K-1.21M-2.07K-4.61K-1.37K-638.05-83.96-374.75-0.20-2.07K
Price/Earnings Growth ratio
-0.0523.85161.67161.50-0.3224.68-1.082.950.231.34-0.00-0.32
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/A49.30%N/AN/A49.17%37.33%51.09%41.48%37.87%41.51%49.17%
Operating Profit Margin
N/AN/A-899.75%N/AN/A-2359.64%-1557.70%-3216.42%-2456.33%-801.40%-2735.57%-2359.64%
Pretax Profit Margin
N/AN/A-899.74%N/AN/A-2405.14%-5189.22%-5309.20%-5214.07%-2494.19%-5499.38%-2405.14%
Net Profit Margin
N/AN/A-899.74%N/AN/A-4411.57%-6599.93%-6686.59%-6288.53%-2494.19%-5499.38%-4411.57%
Effective Tax Rate
-5.36%-0.06%-0.00%3.79%-35.60%-83.42%-27.18%-25.94%-20.60%N/AN/A-35.60%
Return on Assets
-3639.62%-3163.17%-116.91%-1754.11%-1278.09%-1809.96%-5717.77%-889.95%-2894.67%-685.07%-3983.86%-1809.96%
Return On Equity
2201224.78%111.82%97.15%-1783.13%202.76%52.17%78.15%120.97%74.41%43.26%100.09%52.17%
Return on Capital Employed
2082414.52%111.75%97.15%-1837.94%108.58%27.90%18.44%58.19%29.06%13.90%50.94%27.90%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.02N/A
Quick Ratio
0.980.030.0361.430.080.010.000.060.010.040.010.01
Cash ratio
0.550.000.026.200.070.010.000.060.010.030.010.01
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/A5.11KN/AN/A804.46492.81179.27322.39314.29204.95804.46
Operating Cycle
N/AN/A5.11KN/AN/A804.46492.81179.27322.39314.29204.95804.46
Days of Payables Outstanding
N/A23.74K98.29N/AN/A93.76191.7066.04252.0167.52N/A93.76
Cash Conversion Cycle
N/AN/A5.01KN/AN/A710.69301.11113.2270.38246.7750.53710.69
Debt Ratios
Debt Ratio
0.48N/AN/AN/A0.7915.2825.622.9310.503.1639.890.79
Debt Equity Ratio
-290.59N/AN/AN/A-0.12-0.44-0.35-0.39-0.27-0.19-1.02-0.44
Long-term Debt to Capitalization
N/AN/AN/AN/A-0.14N/AN/AN/AN/AN/AN/A-0.14
Total Debt to Capitalization
1.00N/AN/AN/A-0.14-0.78-0.53-0.66-0.37-0.24N/A-0.14
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-1.87N/A
Cash Flow to Debt Ratio
-1.72N/AN/AN/A-4.57-0.45-0.22-0.36-0.57-0.67N/A-4.57
Company Equity Multiplier
-604.79-0.03-0.831.01-0.15-0.02-0.01-0.13-0.02-0.06-0.02-0.15
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/A0.29N/AN/A-16.92-6.54-8.02-13.23-7.83-13.33-16.92
Free Cash Flow / Operating Cash Flow Ratio
1.0211111111111
Cash Flow Coverage Ratio
-1.72N/AN/AN/A-4.57-0.45-0.22-0.36-0.57-0.67N/A-4.57
Short Term Coverage Ratio
-1.72N/AN/AN/AN/A-0.45-0.22-0.36-0.57-0.67-0.94-0.45
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A